SCHEMBL12977445

SCHEMBL12977445

CC(C)CCN(C)CCN(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.61
CA2 P00918 1/20 0.61
CA3 P07451 1/20 0.61
CA4 P22748 1/20 0.61
CA6 P23280 1/20 0.61
CA5A P35218 1/20 0.61
CA7 P43166 1/20 0.61
CA9 Q16790 1/20 0.61
CA14 Q9ULX7 1/20 0.61
CA5B Q9Y2D0 1/20 0.61
ALDH1A1 P00352 3/20 0.36
PIK3CD O00329 1/20 0.36
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TNNI3 P19429 1/20 0.32
TNNT2 P45379 1/20 0.32
TNNC1 P63316 1/20 0.32
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MAPT P10636 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12977413 1.00 CA12 (0.61) CA12CA2CA3CA4CA6
SCHEMBL29580486 0.91 CA12 (0.44) CA12CA2CA3CA4CA6
SCHEMBL29580442 0.91 CA12 (0.44) CA12CA2CA3CA4CA6
SCHEMBL15865606 0.91 CA12 (0.44) CA12CA2CA3CA4CA6
SCHEMBL3410639 0.88 ALDH1A1 (0.42) CA12CA2CA3CA4CA6
SCHEMBL18412613 0.85 CA12 (0.50) CA12CA2CA3CA4CA6
SCHEMBL11932521 0.84 CA12 (0.55) CA12CA2CA3CA4CA6
SCHEMBL10085022 0.84 ALDH1A1 (0.41) CA12CA2CA3CA4CA6
SCHEMBL10081588 0.83 PIK3CD (0.52) CA12CA2CA3CA4CA6
SCHEMBL15182723 0.83 CA12 (0.61) CA12CA2CA3CA4CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024484-B2 Lipid formulations for gene editing VERVE THERAPEUTICS, INC. (US) 2024-07-02 US disclosed
US-12024484-B2 Lipid formulations for gene editing VERVE THERAPEUTICS, INC. (US) 2024-07-02 US disclosed
WO-2021102457-A1 PROCESS OF REDUCING MALODORS ON FABRICS THE PROCTER & GAMBLE COMPANY (US) 2021-05-27 WO disclosed
US-20190194390-A1 AMINO-POLYESTERS FOR DRUG DELIVERY MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2019-06-27 US disclosed
US-8450298-B2 Aminoalcohol lipidoids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-05-28 US disclosed
US-20110293703-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-12-01 US disclosed
US-20100331234-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12024484-B2 Lipid formulations for gene editing LIPA, LIPC, ABHD16A CA12 4570/4885CA2 4630/4885CA3 4792/4885
US-20110293703-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF PHOSPHO1, PNMT, AASDHPPT CA12 4669/4885CA2 4822/4885CA3 4869/4885
US-20100331234-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF PHOSPHO1, PNMT, AASDHPPT CA12 4669/4885CA2 4822/4885CA3 4869/4885
US-20190194390-A1 AMINO-POLYESTERS FOR DRUG DELIVERY DNPEP, NPEPPS, ANPEP CA12 1442/4885CA2 2821/4885CA3 2491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.